Health-care companies rose as traders sought out sectors with less to lose from rising interest rates.
Valneva shares plummeted after its partner Pfizer said it would drop roughly half of the participants enrolled in the companies' late-stage Lyme disease vaccine study.
Pfizer shares ticked up. Investors also bought shares of defensive health insurers, which are less susceptible to the impact of economic slowdowns.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
02-17-23 1704ET
